
OptMyCare is a health technology company founded in 2019, focused on addressing the rising cost crisis in the American healthcare system through its unified AI platform for healthcare and risk management. The company offers precision analytics and actionable risk stratification solutions across multiple chronic conditions. OptMyCare's clinically-engineered algorithms analyze data from over 55 chronic clinical diagnoses, predicting and stratifying member risk to provide insights for informed decision-making and intervention prioritization. Their technology integrates seamlessly with existing health systems, offering improved patient outcomes, reduced hospitalizations, and financial savings for healthcare providers, payers, and patients. The business model appears to be SaaS.

OptMyCare is a health technology company founded in 2019, focused on addressing the rising cost crisis in the American healthcare system through its unified AI platform for healthcare and risk management. The company offers precision analytics and actionable risk stratification solutions across multiple chronic conditions. OptMyCare's clinically-engineered algorithms analyze data from over 55 chronic clinical diagnoses, predicting and stratifying member risk to provide insights for informed decision-making and intervention prioritization. Their technology integrates seamlessly with existing health systems, offering improved patient outcomes, reduced hospitalizations, and financial savings for healthcare providers, payers, and patients. The business model appears to be SaaS.
Founded: 2019
HQ: Dallas, United States
Product: Cloud-based AI SaaS for healthcare risk stratification
Founders: Saravanan Bala, MD, MPH; Antony E. Pfaffle, MD
Employees (approx.): 12
Known funding: Total reported: 3,000,000 USD; last funding 2024-05-02
Rising costs and risk identification in the American healthcare system; chronic disease management and care prioritization.
2019
Healthcare analytics / Health technology
Crunchbase lists a Series A with LiveOak Ventures as lead; specific round amount and date not provided in evidence.
3000000.00
Total funding amount reported as 3,000,000 USD with last funding date 2024-05-02.